Company / Book Value per Share
Harmony Biosciences Holdings, Inc. Book Value per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$15.228
FY2025
5-year range
-$7.433 / $15.228
FY2021-FY2025
Trend
+31.2%
vs FY2024
Sector context
#40 of 209
Health Care
What the data says
Harmony Biosciences Holdings, Inc.'s book value per share of $15.228 is higher than 81% of companies in the Health Care sector (FY2025). Book Value per Share has increased for 6 consecutive years, from -$54.37 in FY2019 to $15.228 in FY2025.
Based on SEC 10-K filings.
$15.228 in FY2025 with a 3-year CAGR of +30.5%. Top quartile in the Health Care sector.
Improved from $7.833 to $15.228 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +30.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-92.9% below sector average
Key checks
Key Insights
- Harmony Biosciences Holdings, Inc.'s book value per share has grown for 6 consecutive years.
- 3-year CAGR of +30.5%, indicating consistent growth.
- In FY2025, book value per share increased 31.2% year-over-year.
- Ranks #40 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.228 | +31.2% |
| FY2024 | $11.611 | +48.2% |
| FY2023 | $7.833 | +14.4% |
| FY2022 | $6.848 | +192.1% |
| FY2021 | -$7.433 | +76.1% |
| FY2020 | -$31.162 | +42.7% |
| FY2019 | -$54.37 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026